Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 15 02:48PM ET
134.35
Dollar change
+1.43
Percentage change
1.08
%
Index- P/E46.39 EPS (ttm)2.90 Insider Own0.00% Shs Outstand3.38B Perf Week6.05%
Market Cap448.52B Forward P/E32.19 EPS next Y4.17 Insider Trans- Shs Float3.34B Perf Month8.83%
Income12.98B PEG16.57 EPS next Q0.80 Inst Own9.53% Short Float0.11% Perf Quarter8.97%
Sales35.52B P/S12.63 EPS this Y25.30% Inst Trans-2.77% Short Ratio0.77 Perf Half Y33.31%
Book/sh3.21 P/B41.82 EPS next Y22.73% ROA32.56% Short Interest3.64M Perf Year58.59%
Cash/sh0.40 P/C332.98 EPS next 5Y2.80% ROE99.99% 52W Range75.56 - 138.28 Perf YTD29.87%
Dividend Est.1.62 (1.21%) P/FCF48.30 EPS past 5Y16.48% ROI77.53% 52W High-2.84% Beta0.42
Dividend TTM1.37 (1.02%) Quick Ratio0.50 Sales past 5Y14.25% Gross Margin84.65% 52W Low77.81% ATR (14)2.70
Dividend Ex-DateMar 22, 2024 Current Ratio0.70 EPS Y/Y TTM52.89% Oper. Margin45.00% RSI (14)66.25 Volatility1.62% 1.87%
Employees63370 Debt/Eq0.27 Sales Y/Y TTM34.74% Profit Margin36.56% Recom1.94 Target Price137.35
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q30.72% Payout36.03% Rel Volume0.70 Prev Close132.92
Sales Surprise2.61% EPS Surprise8.33% Sales Q/Q23.66% EarningsMay 02 BMO Avg Volume4.70M Price134.35
SMA205.99% SMA505.06% SMA20024.58% Trades Volume2,726,476 Change1.08%
Date Action Analyst Rating Change Price Target Change
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Jun-07-22Upgrade JP Morgan Neutral → Overweight
Today 01:59PM
12:03PM
11:23AM
11:02AM
10:37AM
09:50AM Loading…
09:50AM
07:23AM
07:00AM
06:45AM
12:44AM
May-14-24 05:46PM
04:22PM
12:17PM
12:03PM
11:23AM
10:33AM Loading…
10:33AM
10:03AM
10:02AM
09:53AM
09:45AM
09:18AM
07:30AM
07:14AM
04:45AM
04:42AM
May-13-24 07:52PM
04:06PM
03:58PM
03:34PM
12:56PM
12:37PM Loading…
12:37PM
11:49AM
10:45AM
09:07AM
08:47AM
07:00AM
05:57AM
May-12-24 01:25PM
May-11-24 03:50AM
May-10-24 06:00AM
04:41AM
May-09-24 05:44PM
04:32PM
10:20AM
09:45AM
08:41AM
08:30AM
08:26AM
07:13AM
03:00AM
May-08-24 05:27PM
11:31AM
09:30AM
May-07-24 03:21PM
02:04PM
11:29AM
May-06-24 03:02PM
02:44PM
02:40PM
10:38AM
07:15AM
06:32AM
May-04-24 08:30AM
06:45AM
May-03-24 05:07PM
03:15PM
02:53PM
02:39PM
01:48PM
11:35AM
10:51AM
10:41AM
10:12AM
09:50AM
09:41AM
09:03AM
08:58AM
08:36AM
08:16AM
07:54AM
07:47AM
07:04AM
07:00AM
06:36AM
05:00AM
04:17AM
04:02AM
May-02-24 10:26PM
10:10PM
06:01PM
04:17PM
04:08PM
04:02PM
03:58PM
03:22PM
01:59PM
01:08PM
01:00PM
12:55PM
11:54AM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.